Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
OphthaFund is an early-stage investment organization founded in 2019, based in the United States. The firm focuses on the ophthalmology and life sciences sectors, connecting investors with innovative ideas and technologies. It provides extensive research into intellectual property, company guidance, and market analysis for startups and emerging technologies.
Since its inception, OphthaFund has built a portfolio of six companies, emphasizing a meticulous approach to due diligence. The firm aims to identify ventures with strong market potential and clear pathways to commercialization. Its founders have a history of successful investments in biotechnology, which enhances the firm's credibility and expertise in the field.
OphthaFund invests primarily in early-stage companies within the ophthalmology and biotechnology sectors. The firm targets investments at the seed, Series A, and Series B stages, focusing on ventures that demonstrate strong market potential and clear commercialization pathways. The organization emphasizes a thorough due diligence process to evaluate potential investments.
Geographically, OphthaFund concentrates its efforts within the United States, seeking to support innovative healthcare solutions that address unmet needs in the ophthalmology space. The firm looks for founders who possess a deep understanding of their market and a clear vision for their company's growth.
OphthaFund's portfolio includes six notable companies in the biotechnology sector:
These companies reflect OphthaFund's commitment to supporting innovative solutions in the ophthalmology and biotechnology sectors.
George Magrath: Co-Founder & Venture Principal. He has extensive experience in venture capital and a background in biotechnology investments.
Tom Mather: Co-Founder & Venture Principal. Mather brings a wealth of knowledge in early-stage investments and has a strong focus on healthcare innovation.
Andrea Marshall: Co-Founder & Managing Principal. Marshall has a background in life sciences and has led numerous successful investments in the sector.
Jay Thompson, MD: Ophthalmologist Advisor. Thompson provides clinical insights and expertise in ophthalmology, enhancing the firm's investment strategy.
Paul Ryb: Investment Banking Advisor. Ryb's experience in investment banking supports OphthaFund's financial strategies and deal structuring.
Mark Volkmann: Operating Advisor. Volkmann offers operational guidance to portfolio companies, helping them scale effectively.
Rich Sanchez: Investor Relations Advisor. Sanchez manages relationships with investors and stakeholders, ensuring effective communication and engagement.
To pitch OphthaFund, founders should use the contact form available on their website. A comprehensive pitch deck is essential, detailing the business model, market analysis, and team background. Response times may vary, and warm introductions are encouraged but not mandatory.
What are OphthaFund's investment criteria?
OphthaFund focuses on early-stage companies in the ophthalmology and biotechnology sectors. They look for ventures with strong market potential and clear pathways to commercialization.
How can I pitch to OphthaFund?
Founders can reach out through the contact form on OphthaFund's website. A detailed pitch deck outlining the business model, market analysis, and team background is recommended.
What makes OphthaFund different from other investors?
OphthaFund emphasizes a meticulous due diligence process and has a specific focus on the ophthalmology sector, which allows them to identify unique investment opportunities.
What is the typical check size for investments?
OphthaFund invests at the seed, Series A, and Series B stages, but specific check sizes are not publicly disclosed.
What is the geographic scope of OphthaFund's investments?
The firm primarily invests in companies based in the United States, focusing on innovative healthcare solutions.
What kind of support does OphthaFund provide post-investment?
OphthaFund offers guidance in areas such as intellectual property, market analysis, and company strategy to help portfolio companies succeed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.